{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:52:52Z","timestamp":1792050772759,"version":"4.4.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Nutrition"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.advnut.2026.100734","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:42:23Z","timestamp":1789573343000},"page":"100734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nutrition Care and Dietetic Practice in Managing Metabolic and Endocrine Dysfunction in Polyendocrine Metabolic Ovarian Syndrome (PMOS): Implications and Opportunities in the Context of the Name Change of Polycystic Ovarian Syndrome to PMOS"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7816-3422","authenticated-orcid":false,"given":"Donna","family":"Vine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Teede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Bahri-Khomami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10545","key":"10.1016\/j.advnut.2026.100734_bib1","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet."},{"issue":"12","key":"10.1016\/j.advnut.2026.100734_bib2","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ejendo\/lvaf266","article-title":"Increased prospective cardiovascular disease risk in 127 517 Nordic women with polycystic ovary syndrome: a national cohort study","volume":"194","author":"Glintborg","year":"2026","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim","year":"2013","journal-title":"Obes. Rev."},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"International evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil. Steril."},{"issue":"2Part B","key":"10.1016\/j.advnut.2026.100734_bib6","first-page":"314","article-title":"Increased prevalence of adverse health outcomes across the lifespan in those affected by polycystic ovary syndrome: a Canadian Population Cohort","volume":"6","author":"Vine","year":"2023","journal-title":"CJC Open"},{"issue":"10","key":"10.1016\/j.advnut.2026.100734_bib7","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1210\/jc.2017-01354","article-title":"Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome","volume":"102","author":"Rubin","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.advnut.2026.100734_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2147\/IJWH.S165794","article-title":"Measures of health-related quality of life in PCOS women: a systematic review","volume":"10","author":"Behboodi Moghadam","year":"2018","journal-title":"Int. J. Womens Health."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10815-017-1047-7","article-title":"Polycystic ovary syndrome throughout a woman\u2019s life","volume":"35","author":"Bellver","year":"2018","journal-title":"J. Assist. Reprod. Genet."},{"issue":"5","key":"10.1016\/j.advnut.2026.100734_bib11","doi-asserted-by":"crossref","first-page":"e1580","DOI":"10.1210\/clinem\/dgae518","article-title":"Rising incidence, health resource utilization, and costs of polycystic ovary syndrome in the United Kingdom","volume":"110","author":"Berni","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/clinem\/dgab613","article-title":"Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences","volume":"107","author":"Riestenberg","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.advnut.2026.100734_bib13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/obr.12829","article-title":"Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity-A systematic review, meta-analysis, and meta-regression","volume":"20","author":"Khomami","year":"2019","journal-title":"Obes. Rev."},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.fertnstert.2024.01.018","article-title":"Management of polycystic ovary syndrome must include assessment and treatment of mental health symptoms","volume":"121","author":"Alur-Gupta","year":"2024","journal-title":"Fertil. Steril."},{"issue":"51","key":"10.1016\/j.advnut.2026.100734_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/humupd\/dmaf030","article-title":"Prevalence of polycystic ovary syndrome: a global and regional systematic review and meta-analysis","volume":"32","author":"Neven","year":"2026","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib17","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/ejendo\/lvae125","article-title":"Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis","volume":"191","author":"Neven","year":"2024","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.advnut.2026.100734_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103287","article-title":"Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey","volume":"84","author":"Teede","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12978-024-01758-5","article-title":"Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis","volume":"21","author":"Juh\u00e1sz","year":"2024","journal-title":"Reprod. Health"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/01674820903477593","article-title":"Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options","volume":"31","author":"Moran","year":"2010","journal-title":"J. Psychosom. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1186\/s12905-023-02732-2","article-title":"Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care","volume":"23","author":"Sydora","year":"2023","journal-title":"BMC Womens Health"},{"issue":"5","key":"10.1016\/j.advnut.2026.100734_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \u201crisk-enhancing\u201d factor for cardiovascular disease","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-0038-1668086","article-title":"The needs of women and healthcare providers regarding polycystic ovary syndrome information, resources, and education: a systematic search and narrative review","volume":"36","author":"Gibson-Helm","year":"2018","journal-title":"Semin. Reprod. Med."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-022-01208-y","article-title":"Lifestyle management in polycystic ovary syndrome \u2013 beyond diet and physical activity","volume":"23","author":"Cowan","year":"2023","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.advnut.2026.100734_bib26","article-title":"Association of polycystic ovary syndrome with metabolic syndrome and its components in adolescents: a systematic review and meta-analysis","volume":"13","author":"Tu","year":"2026","journal-title":"Front Med. (Lausanne)"},{"issue":"8","key":"10.1016\/j.advnut.2026.100734_bib27","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa061","article-title":"ApoB48-lipoproteins are associated with cardiometabolic risk in adolescents with and without polycystic ovary syndrome","volume":"4","author":"Vine","year":"2020","journal-title":"J. Endocr. Soc."},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib28","first-page":"970","article-title":"Impaired ApoB-lipoprotein and triglyceride metabolism in obese adolescents with polycystic ovary syndrome","volume":"102","author":"Vine","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib29","first-page":"85","article-title":"Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers, Vasc","volume":"22","author":"Patel","year":"2017","journal-title":"Med"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpag.2009.04.004","article-title":"Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome","volume":"23","author":"Bekx","year":"2010","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"7","key":"10.1016\/j.advnut.2026.100734_bib31","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.fertnstert.2011.03.001","article-title":"Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome","volume":"95","author":"Hart","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.advnut.2026.100734_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jpeds.2015.09.082","article-title":"Early biomarkers of subclinical atherosclerosis in obese adolescent girls with polycystic ovary syndrome","volume":"168","author":"Hughan","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.advnut.2026.100734_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1520922","article-title":"Atherogenic ApoB-dyslipidemia, atherosclerotic cardiovascular disease, cardiac dysfunction and remodeling in high-risk young women with and without polycystic ovary syndrome: a pilot study","volume":"16","author":"Wu","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.advnut.2026.100734_bib34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/AOG.0000000000000852","article-title":"Implications of polycystic ovary syndrome for pregnancy and for the health of offspring","volume":"125","author":"Doherty","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/jhn.12444","article-title":"Patient-centred care to improve dietetic practice: an integrative review","volume":"30","author":"Sladdin","year":"2017","journal-title":"J. Hum. Nutr. Diet."},{"issue":"8","key":"10.1016\/j.advnut.2026.100734_bib36","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jamainternmed.2026.1370","article-title":"WENDY Research Group study group, Ovarian cysts in polycystic ovary syndrome","volume":"186","author":"Piltonen","year":"2026","journal-title":"JAMA Intern. Med."},{"issue":"17","key":"10.1016\/j.advnut.2026.100734_bib37","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1161\/CIR.0000000000001423","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"153","author":"Writing Committee Members","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.advnut.2026.100734_bib38","first-page":"S1","article-title":"Diabetes Canada 2018 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada, Can","volume":"42","year":"2018","journal-title":"J. Diabetes"},{"key":"10.1016\/j.advnut.2026.100734_bib39","unstructured":"Canadian Adult Obesity Clinical Practice Guideline. Obesity Canada. [cited 16 September, 2026]. Available from: https:\/\/obesitycanada.ca\/healthcare-professionals\/adult-clinical-practice-guideline\/?gad_source=1&gad_campaignid=22481306521&gbraid=0AAAAADRvApp-Oncgn6jG8fJbLssZ6s01r&gclid=Cj0KCQjwlLDQBhDjARIsAPlIefEPrd37CJXfS8-rNKUYCWi0OjAJOmmohJSV4C9gVB0IY4ObvE3ht-YaAm3aEALw_wcB2020-2025."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.advnut.2026.100734_bib42","article-title":"Effects of polycystic ovary syndrome on liver, heart, muscle, and pancreatic-related diseases","volume":"17","author":"Li","year":"2026","journal-title":"Front Endocrinol"},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib43","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqag001","article-title":"Androgen actions in metabolic tissues in polycystic ovary syndrome","volume":"167","author":"MacRae","year":"2026","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib44","doi-asserted-by":"crossref","DOI":"10.1530\/REP-25-0102","article-title":"Polycystic ovary syndrome: origins and implications: polycystic ovary syndrome: the impact of androgen excess on metabolic health","volume":"170","author":"Cussen","year":"2025","journal-title":"Reproduction"},{"key":"10.1016\/j.advnut.2026.100734_bib45","first-page":"33","article-title":"Understanding the role of androgen action in female adipose tissue, Front Horm","volume":"53","author":"Schiffer","year":"2019","journal-title":"Res"},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib46","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1530\/EJE-17-0124","article-title":"Mechanisms in endocrinology: the sexually dimorphic role of androgens in human metabolic disease","volume":"177","author":"Schiffer","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.advnut.2026.100734_bib47","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/endrev\/bnac001","article-title":"Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification","volume":"43","author":"Dapas","year":"2022","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.advnut.2026.100734_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003132","article-title":"Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis","volume":"17","author":"Dapas","year":"2020","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.advnut.2026.100734_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet"},{"key":"10.1016\/j.advnut.2026.100734_bib50","article-title":"Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome","volume":"15","author":"Wen","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.advnut.2026.100734_bib51","article-title":"Divergent pathophysiological drivers of polycystic ovary syndrome: insulin resistance independently fuels the hyperandrogenic phenotype whilst neuroendocrine factors dominate non-hyperandrogenic presentations","volume":"17","author":"Wang","year":"2026","journal-title":"Front Endocrinol"},{"issue":"7","key":"10.1016\/j.advnut.2026.100734_bib52","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/humrep\/deag064","article-title":"Hypertension and dyslipidemia in women with PCOS: a population-based multiregister study in Sweden","volume":"41","author":"Persson","year":"2026","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib53","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.fertnstert.2008.06.004","article-title":"Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels","volume":"92","author":"Fruzzetti","year":"2009","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/17446651.2021.1865152","article-title":"Tailoring treatment for PCOS phenotypes","volume":"16","author":"Papadakis","year":"2021","journal-title":"Expert Rev. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib55","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s12020-020-02596-8","article-title":"Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome","volume":"72","author":"Krentowska","year":"2021","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib56","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/ijem.IJEM_30_19","article-title":"Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene","volume":"23","author":"Sachdeva","year":"2019","journal-title":"Indian J. Endocrinol. Metab"},{"issue":"8","key":"10.1016\/j.advnut.2026.100734_bib57","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/humrep\/det256","article-title":"The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome","volume":"28","author":"Moran","year":"2013","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.advnut.2026.100734_bib58","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/oby.20213","article-title":"Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women","volume":"21","author":"Teede","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.advnut.2024.100193","article-title":"Prevalence and etiology of eating disorders in polycystic ovary syndrome: a scoping review","volume":"15","author":"Lalonde-Bester","year":"2024","journal-title":"Adv. Nutr."},{"issue":"9","key":"10.1016\/j.advnut.2026.100734_bib60","article-title":"Effect of hyperinsulinemia on leptin and ghrelin levels in polycystic ovarian syndrome: a meta-analysis","volume":"16","author":"Reesor","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib61","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/nutrit\/nuad169","article-title":"Exploring the physiological factors relating to energy balance in women with polycystic ovary syndrome: a scoping review","volume":"83","author":"Nguo","year":"2025","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.advnut.2026.100734_bib62","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.acc.2019.11.004","article-title":"Neurotransmitter, neuropeptide and gut peptide profile in PCOS-pathways contributing to the pathophysiology, food intake and psychiatric manifestations of PCOS","volume":"96","author":"Ilie","year":"2020","journal-title":"Adv. Clin. Chem."},{"issue":"19","key":"10.1016\/j.advnut.2026.100734_bib63","doi-asserted-by":"crossref","first-page":"9702","DOI":"10.3390\/ijms26199702","article-title":"Metabolic and inflammatory adipokine profiles in PCOS: a focus on adiposity, insulin resistance, and atherogenic risk","volume":"26","author":"Koleva-Tyutyundzhieva","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/cen.14647","article-title":"Natural history of polycystic ovary syndrome: a systematic review of cardiometabolic outcomes from longitudinal cohort studies","volume":"96","author":"Kiconco","year":"2022","journal-title":"Clin. Endocrinol."},{"issue":"10","key":"10.1016\/j.advnut.2026.100734_bib65","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents","volume":"88","author":"Silfen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib66","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.advnut.2026.100734_bib67","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1093\/humrep\/dei100","article-title":"Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome","volume":"20","author":"Vural","year":"2005","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib68","first-page":"109","article-title":"Metabolic syndrome in polycystic ovary syndrome","volume":"58","author":"Carmina","year":"2006","journal-title":"Minerva. Ginecol."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib69","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim","year":"2019","journal-title":"Obes. Rev."},{"issue":"11","key":"10.1016\/j.advnut.2026.100734_bib70","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum. Reprod."},{"issue":"12","key":"10.1016\/j.advnut.2026.100734_bib71","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/humrep\/dex308","article-title":"Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes","volume":"32","author":"Tosi","year":"2017","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib72","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4239\/wjd.v13.i3.129","article-title":"Markers of insulin resistance in polycystic ovary syndrome women: an update","volume":"13","author":"Amisi","year":"2022","journal-title":"World J. Diabetes"},{"issue":"9","key":"10.1016\/j.advnut.2026.100734_bib73","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00125-022-05746-x","article-title":"A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome","volume":"65","author":"Liu","year":"2022","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.advnut.2026.100734_bib74","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41574-021-00517-x","article-title":"Epigenetic inheritance of polycystic ovary syndrome-challenges and opportunities for treatment","volume":"17","author":"Stener-Victorin","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"10.1016\/j.advnut.2026.100734_bib75","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.3390\/ijms23084110","article-title":"Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism","volume":"23","author":"Armanini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.advnut.2026.100734_bib76","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/nu18071119","article-title":"Targeting insulin resistance through nutrition: pathophysiological insights and dietary interventions","volume":"18","author":"Caretto","year":"2026","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.advnut.2026.100734_bib77","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1210\/clinem\/dgae481","article-title":"Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with polycystic ovary syndrome","volume":"110","author":"Henney","year":"2025","journal-title":"JCEM"},{"issue":"5","key":"10.1016\/j.advnut.2026.100734_bib78","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/EJE-14-1108","article-title":"Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome","volume":"172","author":"Glintborg","year":"2015","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1530\/EC-20-0527","article-title":"Higher blood pressure in normal weight women with PCOS compared to controls","volume":"10","author":"Mellembakken","year":"2021","journal-title":"Endocr. Connect."},{"issue":"9","key":"10.1016\/j.advnut.2026.100734_bib80","doi-asserted-by":"crossref","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","article-title":"Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study","volume":"106","author":"Berni","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.advnut.2026.100734_bib81","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1210\/clinem\/dgab134","article-title":"Incidence and predictors of hypertension in a cohort of Australian women with and without polycystic ovary syndrome","volume":"106","author":"Joham","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.advnut.2026.100734_bib82","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/10641963.2020.1772815","article-title":"Increased masked hypertension prevalence in patients with polycystic ovary syndrome (PCOS)","volume":"42","author":"\u00d6zkan","year":"2020","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.advnut.2026.100734_bib83","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"2","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.advnut.2026.100734_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13046","article-title":"Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: lifestyle management","volume":"21","author":"Moran","year":"2020","journal-title":"Obes. Rev."},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib85","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jand.2012.11.018","article-title":"Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines","volume":"113","author":"Moran","year":"2013","journal-title":"J. Acad. Nutr. Diet."},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib86","article-title":"Lifestyle changes in women with PCOS","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib87","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1093\/ejendo\/lvad110","article-title":"Body image concerns in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"189","author":"Davitadze","year":"2023","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12905-020-01090-7","article-title":"\u201cThe whole package deal\u201d: experiences of overweight\/obese women living with polycystic ovary syndrome","volume":"20","author":"Ee","year":"2020","journal-title":"BMC Womens Health"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib89","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clnu.2015.02.006","article-title":"Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome","volume":"35","author":"Larsson","year":"2016","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib90","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.fertnstert.2008.04.067","article-title":"Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance","volume":"92","author":"Georgopoulos","year":"2009","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EJE-10-0692","article-title":"Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome","volume":"164","author":"Pasquali","year":"2011","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib92","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/advances\/nmab141","article-title":"Nutritional supplements and complementary therapies in polycystic ovary syndrome","volume":"13","author":"Alesi","year":"2022","journal-title":"Adv. Nutr."},{"issue":"14","key":"10.1016\/j.advnut.2026.100734_bib93","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2174\/0118715303286777240223074922","article-title":"A randomized trial of the efficacy of three weight loss diet interventions in overweight\/obese with polycystic ovary syndrome","volume":"24","author":"Dou","year":"2024","journal-title":"Endocr. Metab. Immune. Disord. Drug Targets."},{"issue":"15","key":"10.1016\/j.advnut.2026.100734_bib94","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3390\/nu17152436","article-title":"Effect of intermittent fasting on anthropometric measurements, metabolic profile, and hormones in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"17","author":"Ranneh","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.advnut.2026.100734_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102927","article-title":"International PCOS guideline clinical research priorities road map: a co-designed approach aligned with end-user priorities in a neglected women\u2019s health condition","volume":"78","author":"Teede","year":"2024","journal-title":"EClinicalmedicine"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib96","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12905-023-02223-4","article-title":"A structural equation model linking health literacy, self-efficacy, and quality of life in patients with polycystic ovary syndrome","volume":"23","author":"Guo","year":"2023","journal-title":"BMC Womens Health"},{"issue":"20","key":"10.1016\/j.advnut.2026.100734_bib97","article-title":"A mixed-method analysis of health literacy and indicators of well-being in women with polycystic ovary syndrome across the lifespan","volume":"20","author":"Douglas","year":"2026","journal-title":"Ther. Adv. Reprod. Health"},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13854","article-title":"Understanding barriers and facilitators to lifestyle management in people with polycystic ovary syndrome: a mixed method systematic review","volume":"26","author":"McGowan","year":"2025","journal-title":"Obes. Rev."},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib99","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity","volume":"26","author":"Rubino","year":"2020","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.advnut.2026.100734_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251566","article-title":"The roles of experienced and internalized weight stigma in healthcare experiences: perspectives of adults engaged in weight management across six countries","volume":"16","author":"Puhl","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.advnut.2026.100734_bib101","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/osp4.379","article-title":"Stigmatizing weight experiences in health care: associations with BMI and eating behaviours","volume":"5","author":"Remmert","year":"2019","journal-title":"Obes. Sci. Pract."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib102","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12935","article-title":"The association between weight stigma and mental health: a meta-analysis","volume":"21","author":"Emmer","year":"2020","journal-title":"Obes. Rev."},{"issue":"7","key":"10.1016\/j.advnut.2026.100734_bib103","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0956797619849440","article-title":"Perceived weight discrimination mediates the prospective association between obesity and physiological dysregulation: evidence from a population-based cohort","volume":"30","author":"Daly","year":"2019","journal-title":"Psychol. Sci."},{"key":"10.1016\/j.advnut.2026.100734_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2021.105612","article-title":"Impact of diagnostic labels and causal explanations for weight gain on diet intentions, cognitions and emotions: an experimental online study","volume":"167","author":"Smith","year":"2021","journal-title":"Appetite"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41366-021-00982-4","article-title":"Internalised weight stigma as a mediator of the relationship between experienced\/perceived weight stigma and biopsychosocial outcomes: a systematic review","volume":"46","author":"Bidstrup","year":"2022","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.advnut.2026.100734_bib106","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.2147\/NDT.S91700","article-title":"Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis","volume":"12","author":"Blay","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"10","key":"10.1016\/j.advnut.2026.100734_bib107","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3390\/jcm8101682","article-title":"Disordered eating behaviours and eating disorders in women in Australia with and without polycystic ovary syndrome: a cross-sectional study","volume":"8","author":"Pirotta","year":"2019","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib108","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.fertnstert.2016.12.014","article-title":"Increased risk of disordered eating in polycystic ovary syndrome","volume":"107","author":"Lee","year":"2017","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.advnut.2026.100734_bib109","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.fertnstert.2018.01.038","article-title":"Androgen Excess- polycystic ovary syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome","volume":"109","author":"Dokras","year":"2018","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.advnut.2026.100734_bib110","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum. Reprod."},{"issue":"12","key":"10.1016\/j.advnut.2026.100734_bib111","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1093\/humrep\/der338","article-title":"Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome","volume":"26","author":"Cinar","year":"2011","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.advnut.2026.100734_bib112","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.3390\/ijerph18052779","article-title":"Depression, anxiety and eating disorder-related impairment: moderators in female adolescents and young adults","volume":"18","author":"Sander","year":"2021","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"10.1016\/j.advnut.2026.100734_bib113","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coemr.2020.04.004","article-title":"Mental health and body image in polycystic ovary syndrome","volume":"12","author":"Lee","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"10.1016\/j.advnut.2026.100734_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.962083","article-title":"Body mass index and quality of life in individuals with polycystic ovary syndrome: dysmorphic concerns and eating disorders as mediators","volume":"10","author":"Barberis","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jcm14010027","article-title":"Polycystic ovary syndrome and eating disorders-A literature review","volume":"14","author":"G\u00f3ral","year":"2024","journal-title":"J. Clin. Med."},{"issue":"21","key":"10.1016\/j.advnut.2026.100734_bib116","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.3390\/ijms21218211","article-title":"Polycystic ovary syndrome: a brain disorder characterized by eating problems originating during puberty and adolescence","volume":"21","author":"Steegers-Theunissen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.advnut.2026.100734_bib117","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612824666171204151209","article-title":"The overlap between binge eating behaviors and polycystic ovarian syndrome: an etiological integrative model","volume":"24","author":"Paganini","year":"2018","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.advnut.2026.100734_bib118","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3390\/nu16071049","article-title":"Food cravings and obesity in women with polycystic ovary syndrome: pathophysiological and therapeutic considerations","volume":"16","author":"Stefanaki","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib119","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1515\/jpem-2025-0151","article-title":"Role of hyperandrogenism on disordered eating behaviors in adolescents with PCOS and interplay with insulin resistance","volume":"39","author":"Kaymaz","year":"2025","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/nu15020295","article-title":"Emotional eating and binge eating disorders and night eating syndrome in polycystic ovary syndrome-a vicious circle of disease: a systematic review","volume":"15","author":"Burnatowska","year":"2023","journal-title":"Nutrients"},{"issue":"16","key":"10.1016\/j.advnut.2026.100734_bib121","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033572","article-title":"2023 International evidence-based polycystic ovary syndrome guideline update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome","volume":"13","author":"Tay","year":"2024","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib122","article-title":"Effects of GLP-1 receptor agonists vs metformin in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Almubaddil","year":"2026","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib123","article-title":"Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials","volume":"15","author":"Lin","year":"2025","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.advnut.2026.100734_bib124","article-title":"The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: a meta-analysis of randomized controlled trials","volume":"38","author":"Morais","year":"2024","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.advnut.2026.100734_bib125","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/9900213","article-title":"Comparative effectiveness of antidiabetic drugs as an additional therapy to metformin in women with polycystic ovary syndrome: a systematic review of metabolic approaches","volume":"2024","author":"Heidarpour","year":"2024","journal-title":"Int. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib126","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jpag.2026.01.001","article-title":"Nonhormonal pharmacological interventions in adolescent polycystic ovary syndrome (PCOS): a systematic review","volume":"39","author":"Sibal","year":"2026","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"7","key":"10.1016\/j.advnut.2026.100734_bib127","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1111\/dom.70779","article-title":"Dietary strategies and nutritional management in patients receiving GLP-1 and dual GIP\/GLP-1 receptor agonists as adjuncts to lifestyle interventions: a systematic review of randomised clinical trials","volume":"28","author":"de Paulo","year":"2026","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib128","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12967-026-07702-4","article-title":"Dietary intake patterns and nutritional adequacy among adults with overweight or obesity treated with GLP-1 or dual GIP\/GLP-1 receptor agonists- preliminary study","volume":"24","author":"Korus","year":"2026","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.advnut.2026.100734_bib129","article-title":"Clinical effects of glucagon-like Peptide-1 agonist use for weight loss in women with polycystic ovary syndrome: a scoping review","volume":"16","author":"Frangie Machado","year":"2024","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.advnut.2026.100734_bib130","article-title":"Semaglutide-associated acute pancreatitis in a patient with type 2 diabetes mellitus: a case report","volume":"18","author":"Puri","year":"2026","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib131","article-title":"Euglycemic ketoacidosis following the use of counterfeit semaglutide for weight loss","volume":"18","author":"Sterckx","year":"2026","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib132","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000046197","article-title":"Diabetic ketoacidosis induced by liraglutide overdose for weight loss in a type 2 diabetes patient: a case report","volume":"105","author":"Xu","year":"2026","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.advnut.2026.100734_bib133","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/dom.70452","article-title":"Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"28","author":"Lu","year":"2026","journal-title":"Diabetes Obes. Metab."},{"issue":"6","key":"10.1016\/j.advnut.2026.100734_bib134","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1111\/dom.70699","article-title":"Safety of GLP-1 and dual GLP-1\/GIP receptor agonists in preconception, pregnancy, and lactation: a systematic review of maternal, fetal, and neonatal outcomes","volume":"28","author":"Ozbek","year":"2026","journal-title":"Diabetes Obes. Metab."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib135","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/eat.24109","article-title":"Use of glucagon-like peptide-1 receptor agonists in eating disorder populations","volume":"57","author":"Bartel","year":"2024","journal-title":"Int. J. Eat. Disord."},{"issue":"1","key":"10.1016\/j.advnut.2026.100734_bib136","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.psc.2025.08.013","article-title":"Use (and potential for abuse) of glucagon-like peptide-1 medications among individuals with eating disorders: empirical review and clinical guidance","volume":"49","author":"Schaefer","year":"2026","journal-title":"Psychiatr. Clin. North Am."},{"issue":"2","key":"10.1016\/j.advnut.2026.100734_bib137","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum. Reprod."}],"container-title":["Advances in Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831326001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2161831326001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:17:01Z","timestamp":1792048621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2161831326001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":136,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2161831326001481"],"URL":"https:\/\/doi.org\/10.1016\/j.advnut.2026.100734","relation":{},"ISSN":["2161-8313"],"issn-type":[{"value":"2161-8313","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrition Care and Dietetic Practice in Managing Metabolic and Endocrine Dysfunction in Polyendocrine Metabolic Ovarian Syndrome (PMOS): Implications and Opportunities in the Context of the Name Change of Polycystic Ovarian Syndrome to PMOS","name":"articletitle","label":"Article Title"},{"value":"Advances in Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advnut.2026.100734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Nutrition.","name":"copyright","label":"Copyright"}],"article-number":"100734"}}